Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2013 1
2014 3
2015 2
2016 1
2017 4
2018 1
2019 3
2020 6
2021 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr; Regain Study Group. Muppidi S, et al. Muscle Nerve. 2019 Jul;60(1):14-24. doi: 10.1002/mus.26447. Epub 2019 Mar 8. Muscle Nerve. 2019. PMID: 30767274 Free PMC article.
Alzheimer's disease, astrocytes and kynurenines.
Dezsi L, Tuka B, Martos D, Vecsei L. Dezsi L, et al. Curr Alzheimer Res. 2015;12(5):462-80. doi: 10.2174/156720501205150526114000. Curr Alzheimer Res. 2015. PMID: 26017558 Review.
Monoamine Oxidase B Inhibitors in Parkinson's Disease.
Dezsi L, Vecsei L. Dezsi L, et al. CNS Neurol Disord Drug Targets. 2017;16(4):425-439. doi: 10.2174/1871527316666170124165222. CNS Neurol Disord Drug Targets. 2017. PMID: 28124620 Review.
Safinamide for the treatment of Parkinson's disease.
Dézsi L, Vécsei L. Dézsi L, et al. Expert Opin Investig Drugs. 2014 May;23(5):729-42. doi: 10.1517/13543784.2014.897694. Epub 2014 Mar 21. Expert Opin Investig Drugs. 2014. PMID: 24650154 Free article. Review.
CANOMAD syndrome with respiratory failure.
Salamon A , Dézsi L , Radics B , Varga ET , Hortobágyi T , Tömösvári A , Vécsei L , Klivényi P , Rajda C . Salamon A , et al. Among authors: dezsi l. Ideggyogy Sz. 2020 Mar 30;73(3-4):141-144. doi: 10.18071/isz.73.0141. Ideggyogy Sz. 2020. PMID: 32364342 Free article. English.
26 results